Sarver Vrooman Wealth Advisors Johnson & Johnson Transaction History
Sarver Vrooman Wealth Advisors
- $150 Billion
- Q1 2025
A detailed history of Sarver Vrooman Wealth Advisors transactions in Johnson & Johnson stock. As of the latest transaction made, Sarver Vrooman Wealth Advisors holds 682 shares of JNJ stock, worth $105,894. This represents 0.08% of its overall portfolio holdings.
Number of Shares
682Holding current value
$105,894% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding JNJ
# of Institutions
4,658Shares Held
1.73BCall Options Held
25MPut Options Held
15.1M-
Vanguard Group Inc Valley Forge, PA234MShares$36.3 Billion0.72% of portfolio
-
Black Rock Inc. New York, NY198MShares$30.8 Billion0.67% of portfolio
-
State Street Corp Boston, MA134MShares$20.8 Billion0.94% of portfolio
-
Geode Capital Management, LLC Boston, MA59.4MShares$9.22 Billion0.79% of portfolio
-
Jpmorgan Chase & CO New York, NY54.1MShares$8.39 Billion0.7% of portfolio
About JOHNSON & JOHNSON
- Ticker JNJ
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,614,479,872
- Market Cap $406B
- Description
- Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...